Affiliation:
1. Samara State Medical University
Abstract
The authors’ report presents a brief review of the key studies, providing the reason for the use of vascular endothelial growth factor as a marker for stratification of the risk of cardiovascular complications in patients with essential hypertension.
Publisher
Cardiology Research Institute
Reference39 articles.
1. Kobalava J.D., Kotovskaya Yu.V., Moiseev V.S. Arterial hypertension. The key to diagnosis and treatment. Moscow: GEOTAR-Media; 2009:864 (In Russ.).
2. Kobyakova O.S., Nesvetaylo N.Ya., Efimova E.V., Boykov V.A. Electronic register of patients with arterial hypertension in Tomsk region. Bulletin of Siberian Medicine. 2012;3:154–160 (In Russ.).
3. Mancia G., de Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G. et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2007;25(6):1105–1187.
4. Mangilyova T.A. Vascular endothelial growth factor system and arterial hypertension. Sertse i sudini. 2012;4:107–115 (In Russ.).
5. Ferroni P., Della-Morte D., Palmirotta R., Rundek T., Guadagni F., Roselli M. Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies. Curr. Vasc. Pharmacol. 2012;10(4):479–493.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献